Hypocretin/orexin, sleep and narcolepsy

BioEssays

Volumn 23, Issue 5, 2001, Pages 397-408

  Hungs, Marcel ^b   Mignot, Emmanuel ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; NEUROPEPTIDE; OREXINS; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; EATING; GENETICS; HISTOLOGY; HUMAN; HYPOTHALAMUS; MOLECULAR GENETICS; NARCOLEPSY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEQUENCE HOMOLOGY; SLEEP;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; EATING; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NARCOLEPSY; NEUROPEPTIDES; SEQUENCE HOMOLOGY, AMINO ACID; SLEEP;

ANIMALIA; CANIS FAMILIARIS;

EID: 0035006525     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.1058     Document Type: Review

References (103)

1. Rechtschaffen A, Gililand MA, Bergmann BM, Winter JB. Physiological correlates of prolonged sleep deprivation in rats. Science 1983;221: 182-184.
2. Kushida CA, Bergrrann BM, Rechtschaffen A. Sleep deprivation in the rat: paradoxical sleep deprivation Sleep 1989;12:22-30.
3. Wager-Smith K, Kay SA. Circad an rhythm genetics: from flies to mice to humans Nat Genet 2000;26:23-27.
4. McCarley RW, Massaquoi SG. Neurobiological structure of the revised limit cycle reciprocal interaction model of REM cycle control. J Sleep Res 1992;1:132-137.
5. McCarley RW, Hobson JA. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model Science 1975;189: 58-60.
6. Kilduff TS. What rest in flies can tell us about sleep in mammals. Neuron 2000;26:295-298.
7. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98:365-376.
8. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M Narcolepsy in orexin knock-out mice molecular genetics of sleep regulation. Cell 1999;98:437-451.
9. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignol E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
10. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kuonerlapati R, Nishino S, Mignot E. A mutation in early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Med 2000;6:991-997.
11. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. Reduced number of hypocretin neurons in human narcolepsy Neuron 2000;27:469-474.
12. De Lecea L, Kilduff TS, Peyron C, Gao X-B, Foye PE, Danielson PE, Fukuhara C, Battenberg ELF, Gautvik VT, Barlett FS, Frankel WN, van den Pool AN, Bloom FE, Gautvik M, Sutcliffe JG. The hypocretins: Hypothalamus-specific peptides with neuroexcilatory activity. Proc Natl Acad Sci USA 1998;95:322-327.
13. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. Orexins and orexin receptors a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92:573-585.
14. Bernardis LL, Bellinger LL. The lateral hypothalamic area revisited: investigated behavior. Neurosci Biobehav Rev 1996;20:189-287.
15. Bernardis LL, Belinger LL. The lateral hypothalamic area revisited: neuroanatomy body weight regulation neuroendocrinoloy and metabolism. Neurosci Biobehav Rev 1993;17:141-193.
16. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.
17. Nambu T, Sakura T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 1999;827: 243-260.
18. Horvath TL, Peyron C, Diano S, Ivanov A, Aston-Jones G, Kilduff TS, van Den Pol AN. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 1999;415: 145-159.
19. van den Pol AN. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord J Neurosci 1999;19:3171-3182.
20. Cutler DJ, Morris R, Sheridhar V, Wattam TA, Holmes S, Patel S, Arch JR, Wilson S, Buckingham RE, Evans ML, Leslie RA, Williams G. Differential distribution of Orexin-A and Orexin-B immunoreactivity in the rat brain and spinal cord. Peptides 1999;20:1455-1470.
21. Chen CT, Dun SL, Kwok EH, Dun NJ, Chang JK. Orexin A-like immunoreactivity in the rat brain. Neurosci Lett 1999;260:161-164.
22. Date Y, Mondai MS, Matsukura S, Ueta Y, Yamashita H, Kaiya H, Kangawa K, Nakazato M. Distribution of orexin/hypocretin in the rat median eminence and pituitary. Mol Brain Res 2000;76:1-6.
23. Date Y, Mondai MS, Matsukura S, Nakazato M. Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord. Neurosci Lett 2000; 286:87-90.
24. Taheri S, Mahmoodi M, Opacka-Juffry J, Ghatei MA, Bloom SR. Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Lett 1999;457:157-161.
25. Mondai MS, Nakazato M, Date Y, Murakami N, Yanagisawa M, Matsukura S. Widespread distribution of orexin in rat brain and its regulation upon fasting. Biochem Biophys Res Commun 1999;256: 495-499.
26. Mondai MS, Nakazato M, Date Y, Murakami N, Hanada R, Sakata T, Matsukura S. Characterization of orexin-A and orexin-B in the micro-dissected rat brain nuclei and their contents in two obese rat models. Neurosci Lett 1999;273:45-48.
27. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 1998;438:71-75.
28. Lu XY, Bagnol D, Burke S, Akil H, Watson SJ. Differential distribution and regulation of OX1 and OX2 Orexin/Hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav 2000;37:335-344.
29. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol (in press).
30. Mignot E. A hundred years of narcolepsy research. Arch Ital Biol (in press).
31. Nishino S, Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol 1997;52:27-78.
32. Bassetti C, Aldrich MS Narcolepsy Neural Clin 1996;14: 45-571.
33. Anic-Labat S, Guilleminault C, Kraemer HC, Meehan J, Arrigoni J, Mignot E. Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep 1999;22:77-87.
34. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998;50 (Suppl 1):S16-S22.
35. Mignot E, Young T, Lin L, Finn L, Palta M. Reduction of REM sleep latency associated with HLA-DQB1*0602 in normal adults. Lancet 1998; 351:727.
36. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, Okun M, Hohjoh H, Miki T, Hsu SH, Leffel MS, Grumet CF, Fernandez-Vina M, Honda M, Risch N. Complex HLA-DR and DQ interactions confer risk for narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001;68:686-699.
37. Baker TL, Foutz AS, McNerney V, Mitler MM, Dement WC. Canine model of narcolepsy: genetic and developmental determinants. Exp Neural 1982;75:729-742.
38. Hungs M, Fan J, Lin L, Lin X, Maki RA, Mignot E. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res (in press).
39. Ripley B, Fujiki N, Okura M, Mignot E, Nishino S. Hypocretin Levels in Sporadic and Familial Canine. Neurobiol Dis (in press).
40. Thannickal TC, Nienhuis R, Ramanathan L, Gulyani S, Turner K, Chestnut B, Siegel JM. Preservation of hypocretin neurons in genetically narcoleptic dogs. Sleep 2000;23(Suppl. 2):A296.
41. Willie JT, Chemelli RM, Xiong Y, Yanagisawa M. A behavioral paradigm that elicits narcoleptic attacks in orexin knockout mice. Sleep 2000; 23(Suppl. 2):A91-92.
42. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M. To eat or to sleep? Orexin and the regulation of sleep and wakefulness. Ann Rev Neurosciences (in press).
43. Chemelli RM, Sinton CM, Yanagisawa M. Polysomnographic characterization of Orexin-2 receptor knockout mice. Sleep 2000;23(Suppl. 2): A296-297.
44. Kisanuki YY, Chemelli RM, Sinton CM, Williams SC, Richardson JA, Hammer RE, Yanagisawa M. The role of orexin receptor Type-1 (OX1R) in the regulation of sleep. Sleep 2000;23(Suppl. 2):A91.
45. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P, Munton RP, Ashmeade TE, Shah AS, Hatcher JP, Hatcher PD, Jones DN, Smith MI, Piper DC, Hunter AJ, Porter RA, Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999;96:10911-10916.
46. Nakamura T, Uramura K, Nambu T, Yada T, Goto K, Yanagisawa M, Sakurai T. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res 2000;873:181-187.
47. Bourgin P, Huttron-Resendez S, Spier AD, Fabre V, Morte B, Criado JR, Sutcliffe JG, Henriksen SJ, de Lecea L Hypocretin-1 Modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 2000;20:7760-7765.
48. Brown RE, Sergeeva OA, Eriksson KS, Haas HL. Orexm-A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology (in press).
49. Mignot E, Nishino S, Sharp LH, Arrigoni J, Siegel JM, Reid MS, Edgar DM, Ciaranello RD, Dement WC Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems. J Neurosci 1993;13:1057-1064.
50. Burlet S, Tyler CJ, Leonard CS. Orexin peptides increase spontaneous frequency of EPSCS in mouse laterodorsal neurons. Soc Neurosci Abstracts 2000;26:1517.
51. Karczmar AG, Longo VG, De Carolis AS. A pharmacological model of paradoxical sleep: the role of cholinergic and monoamine systems. Physiol Behav 1970;5:175-182.
52. Alam MN, Xi X, McGinty D, Szymusiak R. Sleep-waking discharge patterns of neurons in the perifornical area of rat lateral hypothalamus. Sleep 2000;23(Suppl. 2) A10.
53. Estabrook IV, Mc Carthy MT, Ko E, Chou T, Chemelli RM, Yanagisawa M, Saper C, Scammel T. Orexin neuron activity varies with behavioral states. J Neurosci (in press).
54. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000;20:8620-8628.
55. Abrahamson EE, Leak RK, Moore RY. Suprachiasmatic nucleus innervation of posterior hypothalamic hypocretin and melanin-concentrating hormones neurons arousal systems. Soc Neurosci Abstracts 2000; 26:204.
56. Dantz B, Edgar DM, Dement WC. Orcadian rhythms in narcolepsy: studies on a 90 minute day. Electroencephalogr Clin Neurophysiol 1994;90:24-35.
57. Kilduff TS, Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 2000;23: 359-365.
58. Gallopin T, Fort P, Eggermann E, Cauli B, Luppi PH, Rossier J, Audinat E, Muhlethaler M, Serafin M. Identification of sleep-promoting neurons in vitro. Nature 2000;404(6781):992-995.
59. Miller JD, Fauil KF, Bowersox SS, Dement WC. CNS monoamines and their metabolites in canine narcolepsy: a replication study. Brain Res 1990;509:169-171.
60. Nishino S, Honda K, Fujiki N, Wurts SW, Sakurai E, Kato M, Watanabe S, Mignot E, Yanai K. The role of histamine in a hypocretin (orexin)-deficient sleep disorder, narcolepsy. Proc International Sendai Histamine Symposium, Sendai, Japan, 22-25 November 2000, (Elsevier Science, in press)
61. Methippara MM, Alam MN, Szymusiak R, McGinty D Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuroreport 2000;11:3423-3426.
62. Taheri S, Sunter D, Dakin C, Moyes S, Seal L, Gardiner J, Rossi M, Ghatei M, Bloom S Diurnal variation in orexin A immunoreactivity and preproorexin mRNA in the rat central nervous system. Neurosci Lett 2000;279:109-112.
63. Terao A, Peyron C, Ding J, Edgar DM, Heller HC, Kilduff TS. Preprohypocretin (prepro-orexin) expression is unaffected by short-term sleep deprivation in rats and mice. Sleep 2000;23:867-874.
64. Dube MG, Kalra SP, Kalra PS. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res 1999;842:473-477.
65. Dyer CJ, Touchette KJ, Carroll GL, Allee GL, Matteri RL, Cloning of porcine prepro-orexin cDNA and effects of an intramuscular infection of synthetic porcine orexin B on leed intake in young pigs. Domestic Anim Endocrinol 1999;16:145-148.
66. Edwards CM, Abusnana S, Sunter D, Murphy KG, Ghatei MA, Bloom SR. The effect of the orexins on food intake: compar son with neuropeptide Y, melanin-concentrating hormone and galanin J Endocrinol 1999;160:R7-12.
67. Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Tadayyon M, Arch JR. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 1999;20: 1099-1105.
68. Ida T, Nakahara K, Katayama T, Murakami N, Nakazato M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, or the various behavioral activities of rats. Brain Res 1999;821:526-529.
69. Jain MR, Horvath TL, Kalra PS, Kalra SP. Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in satied rats. Regul Pept 2000;87:19-24.
70. Lubkin M, Stricker-Krongrad A. Independent feeding and metabolic actions of orexins in mice. Biochem Biophys Res Commun 1998;253: 241-245.
71. Sweet DC, Levine AS, Billington CJ, Kotz CM. Feeding response to central orexins. Brain Res 1999;821:535-538.
72. Volkoff H, Bjorklund JM, Peter RE. Stimulation of feeding behavior and food consumption in the goldfish, Carassius auratus, by orexin-A and orexin-B. Brain Res 1999;846:204-209.
73. Yamanaka A, Sakurai T, Katsumoto T, Yanagishawa M, Goto K. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight Brain Res 1999; 849:248-252.
74. Yamaraka A, Kunii K, Nambu T, Tsujino N, Sakai A, Matsuzaki I, Miwa Y, Goto K, Sakurai T. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res 2000;859:404-409.
75. Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR, Blundell JE. Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regul Pept 2000;96: 71-84.
76. Haynes AC, Jackson B, Chapman H, Tadayyon M, Johns A, Porter RA, Arch JR. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul Pept 2000;96:45-51.
77. Yamada H, Okumura T, Motomura W, Kobayashi Y, Kongo Y. Inhibition of food intake by central injection of anti-orexin antibody in fasted rats. Biochem Biophys Res Commun 2000;267:527-531.
78. Mullett MA, Billington CJ, Levine AS, Kotz CM. Hypocretin-1 in the lateral hypothalamus activates key feeding-regulatory brain sites. Neuroreport 2000;11:103-108.
79. Schuld A, Hebebrand J, Geller F, Pollmacher T. Increased body-mass index in patients with narcolepsy. Lancet 2000;355:1274-1275.
80. Cai XJ, Widdowson PS, Harrold J, Wilson S, Buckingham RE, Arch JR, Tadayyon M, Claaham JC, Wilding J, Williams G. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes 1999; 48:2132-2137.
81. Griffond B, Risold PY, Jacquemard C, Colard C, Fellmann D. Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area. Neurosci Lett 1999;262:77-80.
82. Hakansson M, de Lecea L, Sutcliffe JG, Yanagisawa M, Meister B. Leptin receptor-and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus. J Neuroendocrinol 1999;11:653-663.
83. Moriguchi T, Sakurai T, Nambu T, Yanagisawa M, Goto K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-incuced acute hypoglycemia. Neurosc. Lett 1999;264:101-104.
84. Cal XJ, Evans ML, Lister CA, Leslie RA, Arch JR, Wilson S, Williams G. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 2001; 50:105-112.
85. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999;20:68-100.
86. Pu S, Jain MR, Kalra PS, Kalra SP. Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner. Regul Pept 1998;78:133-136.
87. Tamura T, Irahara M, Tezuka M, Kiyokawa M, Aono T. Orexins, orexigenic hypothalamic neuropeptides, suppress the pulsatile secretion of luteinizing hormone in ovariectomized female rats. Biochem Biophys Res Commun 1999;264:759-762.
88. Kunii K, Yamanaka A, Nambu T, Matsuzaki I, Goto K, Sakurai T. Orexins/hypocretins regulate drinking behaviour. Brain Res 1999;842: 256-261.
89. Harrison TA, Chen CT, Dun NJ, Chang JK. Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla Neurosci Lett 1999;273:17-20.
90. Dun NJ, Le Dun S, Chen C, Hwang LL, Kwok EH, Chang J. Orexins: a role in medullary sympathetic outflow. Regul Pept 2000;96:65-70.
91. Samson WK, Goswell B, Chang JK, Resch ZT, Murphy TC. Cardiovascular regulatory actions of the nypocretins in the brain. Brain Res 1999;831:248-253.
92. Chen CT, Hwang LL, Chang JK, Dun NJ. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am J Physiol Regul Integr Comp Physiol 2000;278:R692-R697.
93. Shirasaka T, Nakazato M, Matsukura S, Takasaki M, Kannan H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol 1999;277:R1780-R1785.
94. Takahashi N, Okumura T, Yamada H, Kohgo Y. Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats. Biochem Biophys Res Commun 1999;254:623-627.
95. Russell SH, Kim MS, Small CJ, Abbott CR, Morgan DG, Taheri S, Murphy KG, Todd JF, Ghatei MA, Bloom SR. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactir. J Neuroendocrinol 2000;12:1213-1218.
96. Jaszberenyi M, Bujdoso E, Pataki I, Telegdy G. Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 2000;12: 1174-1178.
97. Malendowicz LK, Tortorella C, Nussdorfer GG. Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade. J Steroid Biochem Mol Biol 1999;70:185-188.
98. Nowak KW, Mackowiak P Switonska MM Fabis M, Malendowicz LK. Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. Life Sci 2000;66:449-454.
99. Lopez-Lozano JJ, Mata M, Bravo G. Neural transplants in Parkinson disease: clinical results of 10 years of experience. Group of Neural Transplants of the CPH Rev Neural 2000;30:1077-1083.
100. Rosenberg L. Pancreatic and Islet Transplantation. Curr Gastroenterol Rep 2000;2:165-172.
101. Sakurai T, Moriguchi T, Furuya K, Kajiwara N, Nakamura T, Yanagisawa M, Goto K. Structure and function of human prepro-orexin gene. J Biol Chem 1999;274:17771-17776.
102. Shibahara M, Sakurai T, Nambu T, Takenouchi T, Iwaasa H, Egashira SI, Ihara M, Goto K. Structure, tissue distribution and pharmacological characterization of Xenopus orexins. Peptides 1999;20:1169-1176.
103. Asahi S, Egashira EI, Matsuda M, Iwaasa H, Kanatani A, Ohkubo M, Sakurai T, Morishima H. Structure-Activity Relationship Studies on the Novel Neuropeptide Orexin. In Fujii N. ed; Peptide Science, The Japanese Peptide Society 1999. p 37-40.